Global and China Hemodialysis Industry Report, 2013-2016

109 pages report Published in
Medical Devices
Publisher: Research In China

arrowFor This Report

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure.

In 2013, the global number of patients receiving dialysis continued to grow to 2.519 million. The new patients mainly come from Asia Pacific region (excluding Japan), whereas for Europe, America, Japan and other mature markets, since these countries have a higher proportion of patients with advanced renal failure receiving treatment, so they have a slower growth in the number of patients receiving dialysis. For example, in 2013, the number of patients receiving dialysis in Asia-Pacific region grew by 17.0% YoY; while in Japan, EU and US, the number of patients receiving dialysis grew by only 2%-4% YoY.

The global hemodialysis market can be divided into two parts: hemodialysis service and hemodialysis equipment, of which the scale of hemodialysis service market is larger, accounting for about 85% of the overall market.

1 Hemodialysis Service Market

Global hemodialysis service market has great regional differences: in Europe and Asia Pacific, public institutions dominate, however, in North America, private-company-operated institutions and in Latin America, private clinics are the main forms. Currently, global companies providing hemodialysis service mainly include Fresenius Medical Care, DaVita, etc. The number of patients receiving hemodialysis in these two companies in 2013 came to nearly 340,000.

Dialysis services in China are mainly provided by all levels of hospitals, mainly due to that currently the national health insurance reimbursement ratio is relatively low and the affordability of patients is not high, resulting in lower proportion of patients with end-stage renal disease undergoing dialysis treatment, which was only about 12% in 2013. In 2013 the number of Chinese patients with renal failure undergoing dialysis treatment (mainly hemodialysis treatment) was approximately 250,000, and number of patients undergoing peritoneal dialysis was less than 30,000. But with the gradual expansion of China’s health insurance coverage at all levels, the proportion of patients with end stage renal disease undergoing treatment will rise sharply and the market prospects will be very promising.

2 Dialysis Equipment Market

The global hemodialysis equipment market is relatively concentrated, mainly dominated by European, American and Japanese companies. The first-tier brands are American and European brands, including Germany-based Fresenius and Braun, U.S.-based Baxter and so on; the second-tier brands mainly are Japanese brands, including NIKKISO, Nipro, Toray and so on. In 2013, market share of Fresenius and Baxter in the global dialysis equipment market reached 34% and 30% respectively.

Local Chinese hemodialysis equipment has poor competitiveness and low market share. In 2013, China’s hemodialysis equipment import dependency rate was about 70%. Chinese manufacturers in the field of dialysis include: hemodialysis machine manufacturers like Jihua Medical Apparatus and Instruments Co., Ltd, Guangdong Biolight Meditech Co., Ltd and Chongqing Shanwaishan Science & Technology Co., Ltd; dialyzer manufacturers include Shandong Weigao Group and Jiangsu Lengthen Life Science and Technology Co., Ltd; peritoneal dialysis solution manufacturers include Huaren Pharmaceutical Co., Ltd and Sichuan Kelun Pharmaceutical Co., Ltd.

The “Global and China Hemodialysis Industry Report, 2013-2016” published by ResearchInChina includes the following main contents:

  • Global hemodialysis population and distribution, etc.;
  • Status quo, competition pattern and development trend of the global hemodialysis equipment and service markets;
  • Market scale, competition pattern, import & export and development forecasting, etc of China hemodialysis industry;
  • Status quo and competition pattern of global and China hemodialysis equipment market segments;
  • Operational analysis, hemodialysis business analysis and development forecasting of 16 global and Chinese enterprises in the hemodialysis industry.

Table of Contents

1 Hemodialysis Industry Overview
1.1 Definition
1.2 Hemodialysis Equipment
1.3 Hemodialysis Service
1.3.1 In-Center Hemodialysis
1.3.2 Home Hemodialysis
1.4 Industry Chain

2 Global Hemodialysis Market
2.1 Dialysis Population
2.2 Overall Market Situation
2.3 Hemodialysis Equipment Market
2.4 Hemodialysis Service Market

3 China Hemodialysis Market
3.1 Status Quo
3.2 Policy Environment
3.3 Competition Pattern
3.4 Market Scale

4 China Hemodialysis Equipment Import and Export
4.1 Import
4.2 Export

5 Hemodialysis Market Segments
5.1 Hemodialysis Machine
5.2 Peritoneal Dialysis
5.3 Dialyzer
5.4 Dialysis Loop Tube
5.5 Dialysis Concentrate
5.6 Hemodialysis Machine for Home Use
5.7 Hemodialysis Membrane

6 Major Foreign Manufacturers
6.1 Fresenius Medical Care
6.1.1 Profile
6.1.2 Operation
6.1.3 Dialysis Product Business
6.1.4 Dialysis Service Business
6.1.5 Number of Patients Receiving Dialysis
6.1.6 Development Situation
6.1.7 Business in China
6.2 NIKKISO
6.2.1 Profile
6.2.2 Operation
6.2.3 Hemodialysis Business
6.2.4 Business in China
6.3 Baxter
6.3.1 Profile
6.3.2 Operation
6.3.3 Hemodialysis Business
6.3.4 Acquisition of Gambro AB
6.3.5 Operating Conditions in China
6.4 Asahi Kasei
6.4.1 Profile
6.4.2 Operation
6.4.3 Operating Conditions of the Health Care Division
6.4.4 Business in China
6.5 Nipro
6.5.1 Profile
6.5.2 Operation
6.5.3 Hemodialysis Business
6.5.4 Business in China
6.6 B. Braun Melsungen AG
6.6.1 Profile
6.6.2 Operation
6.6.3 Hemodialysis Business
6.6.4 Business in China
6.7 Nxstage
6.7.1 Profile
6.7.2 Operation
6.7.3 Portable Hemodialysis Machine Business
6.7.4 Hemodialysis Consumables Business

7 Major Manufacturers in China
7.1 Weigao Group
7.1.1 Profile
7.1.2 Operation
7.1.3 Revenue Structure
7.1.4 R & D
7.1.5 Hemodialysis Business
7.1.6 Development Prospects and Forecasting
7.2 Huaren Pharmaceutical
7.2.1 Profile
7.2.2 Operation
7.2.3 Hemodialysis Business
7.3 Guangdong Biolight Meditech
7.3.1 Profile
7.3.2 Operation
7.3.3 Revenue Structure
7.3.4 Gross Margin
7.3.5 R & D
7.3.6 Clients
7.3.7 Hemodialysis Business
7.3.8 Forecasting and Outlook
7.4 Kelun Pharmaceutical
7.4.1 Profile
7.4.2 Operation
7.4.3 Hemodialysis business
7.5 Jihua Medical Apparatus and Instruments
7.5.1 Profile
7.5.2 Hemodialysis Business
7.6 Bain Medical Equipment
7.6.1 Profile
7.6.2 Operation
7.6.3 Hemodialysis Business
7.7 Beijing United Bio-Tech
7.7.1 Profile
7.7.2 Operation
7.8 Jiangsu Lengthen Life Science and Technology
7.8.1 Profile
7.8.2 Operation
7.8.3 Hemodialysis Business
7.9 Guangzhou Koncen BioScience
7.9.1 Profile
7.9.2 Operation

8 Summary and Forecasting
8.1 Summary
8.2 Development Forecasting
8.2.1 Increasing Hemodialysis Population
8.2.2 Steadily Increasing Proportion of Dialysis Treatment
8.2.3 Market Size Forecasting

List of Charts

Pros and Cons of In-Center Hemodialysis
Pros and Cons of Home Hemodialysis
Hemodialysis Industry Chain
Global Number of Nephritic Patients Receiving Dialysis, 1990-2020E
Global Number of Patients Receiving Dialysis Treatment, 2011-2013
Patients Receiving Dialysis Treatment Worldwide by Region, 2011-2013
Patients Receiving Dialysis Treatment Worldwide by Country, 2011-2013
Competition Structure of Global Dialysis Equipment Market, 2013
Competition Structure of Global Hemodialysis Machine Market, 2013
Competition Structure of Global Peritoneal Dialysis Equipment Market, 2013
Global Number of Patients with Advanced Renal Failure by Treatment Method, 2011-2013
Proportions of Global Number of Patients with Advanced Renal Failure (by Treatment Method), 2011-2013
Service Forms of Global Dialysis Industry (by Region), 2013
Service Forms of Major Countries and Regions in Global Dialysis Industry, 2013
Number of Patients Receiving Dialysis at the World's Top Five Dialysis Service Providers, 2013
Number of Patients Receiving Dialysis at the World’s Leading Hemodialysis Service Providers (by Region), 2013
Amount of China’s Hemodialysis Equipment Trade Deficit, 2008-2013
Products of China’s Major Hemodialysis Machine Manufacturers Holding Medical Device Registration Certificate, 2013
Geographical Distribution of Chinese Dialysis Equipment Manufacturers, 2013
China's Dialysis Market Size, 2013
China's Hemodialysis Equipment Import Value and Growth Rate, 2009-2013
China's Hemodialysis Equipment Import Volume and Growth Rate, 2009-2013
China's Hemodialysis Equipment Import Source Structure (by Import Value), 2011-2013
Comparison by Average Unit Price of China’s Hemodialysis Equipment Imports (by Country), 2011-2013
China’s Hemodialysis Equipment Import Value Structure by Province/City, 2011-2013
China's Hemodialysis Equipment Export Value and Growth Rate, 2009-2013
China's Hemodialysis Equipment Export Destination Structure (by Export Value), 2013
China's Hemodialysis Equipment Export Value Structure by Province/City, 2013
Introduction of Some Small Hemodialysis Machines
Five Branches of Fresenius Group
Net Revenue and Net Income of Fresenius Medical Care, 2009-2013
Net Revenue Structure of Fresenius Medical Care (by Product), 2011-2013
Net Revenue Structure of Fresenius Medical Care (by Region), 2011-2013
Net Revenue and Growth Rate of Dialysis Products of Fresenius Medical Care, 2009-2013
Net Revenue Structure of Dialysis Products of Fresenius Medical Care (by Region), 2011-2013
Revenue and Growth Rate of Dialysis Service of Fresenius Medical Care, 2009-2013
Net Revenue Structure of Dialysis Service of Fresenius Medical Care (by Region), 2011-2013
Number of Patients Receiving Dialysis Treatment at Fresenius Medical Care and YoY Growth Thereof, 2009-2013
Proportion of Patients Receiving Dialysis Treatment at Fresenius Medical Care (by Region), 2011-2013
Market Share of Fresenius Medical Care in the World's Major Markets (by Number of Patients Receiving Dialysis), 2013
Production Plants and Main Products of Fresenius Medical Care, 2013
Operation of Fresenius Medical Care's Subsidiaries in China, 2013
Main Business of NIKKISO by Division, 2013
Net Sales and Net Income of NIKKISO, FY2008-FY2012
Net Sales Structure of NIKKISO (by Division), FY2012
Net Sales Structure of NIKKISO (by Region), FY2012
Hemodialysis-Related Factories of NIKKISO, 2013
Net Sales and YoY Growth of Medical Division of NIKKISO, FY2008-FY2012
Main Business and Products of Baxter
Net Sales and Net Income of Baxter, 2009-2013
Net Sales Structure of Baxter (by Division), 2011-2013
Net Sales Structure of Baxter (by Region), 2011-2013
Net Sales Structure of Medical Products Division of Baxter (by Product), 2011-2013
Net Sales and YoY Growth of Renal Business of Baxter, 2009-2013
Net Sales Structure of Renal Business of Baxter (by Region), 2010-2012
Net Sales and EBITDA of Gambro AB, 2008-2012
Main Business of Baxter’s Factories in China, 2012
Main Business of Nine Core Operating Companies of Asahi Kasei
Net Sales and Net Income of Asahi Kasei, FY2008-FY2012
Net Sales Structure of Asahi Kasei (by Division), FY2010-FY2012
Net Sales and Operating Income of Health Care Division of Asahi Kasei, FY2008-FY2012
Major Affiliates of Asahi Kasei Medical
Operating Revenue and Operating Income of Asahi Kasei Medical (Hangzhou), 2007-2009
Three Major Business Segments and Specific Business of Nipro
Net Sales and Net Income of Nipro, FY2008-FY2012
Sales Structure of Nipro (by Business), FY2012
Sales Structure of Nipro (by Region), FY2012
Net Sales and Operating Income of Medical-Care-Related Business of Nipro, FY2008-FY2012
Net Sales and Operating Income of Pharmaceutical-Related Business of Nipro, FY2008-FY2012
Business of Nipro’s Subsidiaries in China
Hemodialysis Products of Nipro Trading (Shanghai)
Operating Revenue and Total Profit of Nipro Trading (Shanghai), 2007-2009
Main Business of Four Divisions of B.Braun
Sales and EBITDA of B.Braun, 2009-2013
Sales Structure of B.Braun (by Division), 2011-2013
Sales Structure of B.Braun (by Region), 2011-2013
Sales Structure of B.Braun (by Product and Service), 2011-2013
Sales and YoY Growth of B.Braun Avitum, 2009-2013
Main Business of B.Braun’s Subsidiaries in Mainland China, 2013
Sales of B.Braun Avitum (Shanghai) Trading Company Limited, 2009-2013
Main Business Divisions and Business of Nxstage
Total Revenue and Gross Profit of Nxstage, 2009-2013
Revenue Structure of Nxstage (by Division), 2011-2013
Revenue and Gross Profit of Portable Hemodialysis Machine Division of Nxstage, 2009-2013
Revenue Structure of Portable Hemodialysis Machine Division of Nxstage (by Business), 2011-2013
Revenue and Gross Profit of Hemodialysis Consumables of Nxstage, 2008-2012
Product Line of Weigao Group
Revenue and Net Income of Weigao Group, 2009-2013
Revenue Breakdown of Weigao Group (by Product), 2011-2013
Output of Main Products of Weigao Group, 2011-2013
Revenue Structure of Weigao Group (by Product), 2011-2013
Revenue Breakdown of Weigao Group (by Region), 2011-2013
Revenue Structure of Weigao Group (by Region), 2011-2013
R&D Costs and % of Total Revenue of Weigao Group, 2010-2012
Hemodialysis-Related Subsidiaries of Weigao Group, 2013
Revenue and Net Income of Weigao Group, 2012-2016E
Revenue and Net Income of Huaren Pharmaceutical, 2009-2013
Revenue and Net Income of Guangdong Biolight Meditech, 2009-2013
Revenue Breakdown of Guangdong Biolight Meditech (by Product), 2011-2013
Revenue Structure of Guangdong Biolight Meditech (by Product), 2011-2013
Revenue Breakdown of Guangdong Biolight Meditech (by Region), 2011-2013
Revenue Structure of Guangdong Biolight Meditech (by Region), 2011-2013
Gross Margin of Main Products of Guangdong Biolight Meditech, 2011-2013
R&D Costs and % of Total Revenue of Guangdong Biolight Meditech, 2011-2013
Guangdong Biolight Meditech’s Revenue from Top 5 Clients and % of Total Revenue, 2011-2013
Name List, Revenue Contribution and % of Guangdong Biolight Meditech's Top 5 Clients, 2013
Hemodialysis-Related Subsidiaries of Guangdong Biolight Meditech, 2013
Output and Sales Volume of Dialysis Solution/Powder of Guangdong Biolight Meditech, 2012-2013
Revenue and Net Income of Guangdong Biolight Meditech, 2012-2016E
Revenue and Net Income of Kelun Pharmaceutical, 2009-2013
Revenue and Net Income of Chengdu Qingshan Likang Pharmaceutical, 2012-2013
Hemodialysis Series Products of Jihua Medical Apparatus and Instruments
Operating Revenue, Total Profit and Gross Margin of Bain Medical Equipment, 2008-2009
Operating Revenue, Total Profit and Gross Margin of Beijing United Bio-Tech, 2007-2009
Operating Revenue, Total Profit and Gross Margin of Jiangsu Lengthen Life Science and Technology, 2007-2009
Shareholding Structure of Guangzhou Koncen Bioscience as of 2013
Product Line of Guangzhou Koncen Bioscience
Key Financial Indicators of Guangzhou Koncen Bioscience, 2012-2013
Operation Comparison between Global and Chinese Hemodialysis Enterprises, 2013
Positive Correlation between the Number of ESRD Patients per Million Population and GDP Per Capita
China Hemodialysis Market Size, 2013-2016E

Related Reports

  • Research and Development Prospect of China Dialysis Market, 2014-2018Based on the 2013 version, this update Report provides detailed analysis on Chinese government policies about dialysis industry and the relevant effect in recent three years, and conducts in-depth research about dialysis industry segmentations. Moreover, it analyzes Chinese private-owned hemodialysis services. In the aspect of enterprises, this update Report not only updates the latest information about the key enterprises listed in 2013 version, but also adds the information about […]
  • Merz Pharma GmbH & Co. KgaA – Product Pipeline Review – 2014Global Markets Direct's, ‘Merz Pharma GmbH & Co. KgaA Product Pipeline Review 2014', provides an overview of the Merz Pharma GmbH & Co. KgaA's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Merz Pharma GmbH & Co. KgaA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) […]
  • 2016 US Point-of-Care/POC Infectious Disease Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent SuppliersThis new 795-page report from VPGMarketResearch.com contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease […]
  • North America Digital Orthodontics Industry 2016 Market Research ReportThe North America Digital Orthodontics Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Digital Orthodontics industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Digital Orthodontics market analysis is provided for the North America markets including development trends, competitive landscape analysis, and key regions development […]
  • US Hepatitis Diagnostics Market 2015: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices–Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT ProceduresThe report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: Hospitals Commercial/Private Labs Blood Banks Physician Offices Public Health […]